Albert-Roussel pharma

Albert-Roussel Pharma was a German pharmaceutical company that operated as a key subsidiary within the Hoechst and Roussel Uclaf corporate structure. The company was primarily focused on the marketing, sales, and distribution of a diverse portfolio of pharmaceutical products in the German market. Its therapeutic strengths lay in infectious diseases, rheumatology, and cardiovascular health, managing well-known brands such as the antibiotics Claforan and Rulid. Albert-Roussel Pharma played a significant role in the mid-to-late 20th-century European pharmaceutical landscape before the era of massive industry consolidation. In 1995, the company was absorbed into Hoechst Marion Roussel (HMR) following the merger of Hoechst's drug business with Marion Merrell Dow. Through subsequent mergers involving Aventis and Sanofi-Synthélabo, the legacy of Albert-Roussel Pharma is now part of Sanofi.